Rasoul BAHARLOU, Mohammad Hassan DAVAMI, Abbas AHMADI VASMEHJANI, Morteza EBRAHIMI

Increased IL-17 and TGF-ß serum levels in peripheral blood of patients with ß-thalassemia major: implication for continual transfusions role in T helper 17-mediated proinflammatory responses

Background/aim: Recent studies have shown that IL-17-producing CD4+ T helper (Th17) cells play an important role in proinflammatory processes. In this report we analyzed IL-17, IL-21, and TGF-β serum levels in the peripheral blood of Iranian beta-thalassemia major patients that clinically exhibited splenectomy and iron overload. Materials and methods: Blood samples were collected from 43 beta-thalassemia patients and 43 healthy individuals with no history of malignancies or autoimmune disorders. Then serum levels of IL-17, IL-21, and TGF-β were measured by enzyme linked immunosorbent assay (ELISA). Results: The levels of IL-17 (P = 0.005) and TGF-β (P < 0.001) were significantly higher in the thalassemia patients compared to the healthy control. No significant differences in the level of serum IL-21 was observed between the patients and controls. There were no significant differences in serum levels of IL-17, IL-21, and TGF-β between patients with high or low serum levels of ferritin. Conclusion: Multiple blood transfusions cause constant immune stimulation, as a result of repeated exposure to new alloantigens. This might have significant effects on the stimulation of cytokine producing cells in those patients and cytokine profile can be used as a related marker for assessing disease severity and consequently therapeutic intervention.

PDF

___

1. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med 2005; 353: 1135-1146.
2. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-761.
3. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin Invest 2002; 32 Suppl 1: 70-78.
4. Cunningham-Rundles S, Giardina PJ, Grady RW, Califano C, McKenzie P, De Sousa M. Effect of transfusional iron overload on immune response. J Infect Dis 2000; 182 Suppl 1: S115-S121.
5. Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit 2003; 9: RA19-22.
6. Bozdogan G, Erdem E, Demirel GY, Yildirmak Y. The role of Treg cells and FoxP3 expression in immunity of β-thalassemia major and β-thalassemia trait patients. Pediatr Hematol Oncol 2010; 27: 534-545.
7. Kadymova EA. The features of immune status of major betathalassemia patients during various periods after splenectomy. Georgian Med News 2009: 39-44 (in Russian).
8. Bao W, Zhong H, Li X, Lee MT, Schwartz J, Sheth S, Yazdanbakhsh K. Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. Am J Hematol 2011; 86: 1001-1006.
9. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
10. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002; 2: 933-944.
11. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
12. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
13. Xu S, Cao X. Interleukin-17 and its expanding biological functions. Cell Mol Immunol 2010; 7: 164-174.
14. Louten J, Boniface K, de Waal Malefyt R. Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-1011.
15. Peck A, Mellins ED. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 2009; 132: 295-304.
16. Sallusto F, Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect 2009; 11: 620-624.
17. Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S et al. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 2008; 68: 3915-3923.
18. Passos ST, Silver JS, OHara AC, Sehy D, Stumhofer JS, Hunter CA. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 2010; 184: 1776-1783.
19. Mucida D, Cheroutre H. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr 2007; 1: 142-144.
20. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260.
21. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10: 479-489.
22. Khatami M. Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases. Cell Biochem Biophys 2009; 55: 55- 79.
23. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23- IL-17 immune pathway. Trends Immunol 2006; 27: 17-23.
24. Toussirot E. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targets 2012.
25. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454: 350-352.
26. Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol 2009; 88: 21-27.
27. Ozturk O, Yaylim I, Aydin M, Yilmaz H, Agachan B, Demiralp E, Isbir T. Increased plasma levels of interleukin-6 and interleukin-8 in beta-thalassaemia major. Haematologia (Budap) 2001; 31: 237-244.
28. Gangemi S, Merendino RA, Meo A, Minciullo PL, Briuglia S, Merlino MV, Rigoli L, Tomasello C, Salpietro CD. Serum levels of interleukin-18 in splenectomized and nonsplenectomized thalassemic patients: preliminary considerations. Acta Haematol 2003; 110: 45-47.
29. Wanachiwanawin W, Wiener E, Siripanyaphinyo U, Chinprasertsuk S, Mawas F, Fucharoen S, Wickramasinghe SN, Pootrakul P, Visudhiphan S. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in beta(o)- thalassemia/HbE and their clinical significance. J Interferon Cytokine Res 1999; 19: 105-111.
30. Butthep P, Rummavas S, Wisedpanichkij R, Jindadamrongwech S, Fucharoen S, Bunyaratvej A. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. Am J Hematol 2002; 70: 100- 106.
31. Balouchi S, Gharagozloo M, Esmaeil N, Mirmoghtadaei M, Moayedi B. Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy. Immunopharmacology and immunotoxicology 2014; 1-4.
32. Salsaa B, Zoumbos N. A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with β‐thalassaemia. Clinical & Experimental Immunology 1997; 107: 589-592.
33. Mencacci A, Cenci E, Boelaert JR, Bucci P, Mosci P, dOstiani CF, Bistoni F, Romani L. Iron overload alters innate and T helper cell responses to Candida albicans in mice. Journal of Infectious Diseases 1997; 175: 1467.
34. Omara FO, Blakley BR. The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse. British Journal of Nutrition. 1994; 72: 899-909.
35. Moshtaghi-Kashanian GR, Gholamhoseinian A, Hoseinimoghadam A, Rajabalian S. Splenectomy changes the pattern of cytokine production in beta-thalassemic patients. Cytokine 2006; 35: 253-257.
36. Lombardi G, Matera R, Minervini MM, Cascavilla N, DArcangelo P, Carotenuto M, Di Giorgio G, Musto P. Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status. Haematologica 1994; 79: 406-412.
37. Appay V, Rowland-Jones SL. Premature ageing of the immune system: the cause of AIDS? Trends in Immunology 2002; 23: 580-585.